GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH).

MPC is previously thought to be Mullerian duct cyst, causing EDO and male infertility through oppressing ejaculatory duct. [4] Recent researches reveal that not all cystic lesions are located in the ...

Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...

Objective: To compare the effectiveness and risk profile of minimally invasive interventions against the current standard of transurethral resection of the prostate. Design: Systematic review and meta ...

PHILADELPHIA (WPVI) -- Benign prostatic hyperplasia (BPH), a noncancerous enlargement of the prostate gland, is the most common benign tumor found in men. BPH produces symptoms by obstructing the flow ...

Benign prostatic hyperplasia (BPH) remains a significant clinical condition affecting ageing men worldwide, characterised by enlargement of the prostate gland and associated lower urinary tract ...

DEAR DR. ROACH: I am 79. Two recent tests confirmed that my PSA level was 4.6 ng/mL. Previously, my results were never higher than 1.4 ng/mL. Flomax has been a necessity for me for the past 20 years, ...

The latest treatments for an enlarged prostate may help reduce prostate size or reduce symptoms. Treatments include water vapor thermal therapy, prostatic urethral lift, and prostate artery ...